Q1/2024 3/31/2024 EPS -0.310 ZacksConsensus -0.110 ActVsEst (0.200) - Miss
Capricor Therapeutics, Inc. (CAPR)
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
capricor.com/investors
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
CAPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAPR alerts
High impacting Capricor Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CAPR
News
- Here's What Could Help Capricor (CAPR) Maintain Its Recent Price Strength [Yahoo! Finance]Yahoo! Finance
- Capricor Therapeutics files to sell 2.8M shares of common stock for holders [Seeking Alpha]Seeking Alpha
- Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $35.00 price target on the stock.MarketBeat
- Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesGlobeNewswire
- Capricor Therapeutics stock falls after pricing $75M equity offering [Seeking Alpha]Seeking Alpha
CAPR
Earnings
- 8/7/24 - Miss
CAPR
Sec Filings
- 10/24/24 - Form SC
- 10/22/24 - Form S-3
- 10/17/24 - Form 424B5
- CAPR's page on the SEC website